Antidote for Overdose Deaths Approved as Opioid Epidemic Surges

  • FDA clears nasal spray version of Narcan made by Adapt Pharma
  • Drug will be marketed in packages of two devices for $75

The antidote for prescription painkillers and heroin overdoses will now be sold as an approved nasal spray version that could make it easier for first responders and family members to revive drug addicts.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.